NDC codes

FDA NDC Directory
Product NDC (as listed)0115-1750Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00115-1750Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0115-1750-080011517500830 CAPSULE in 1 BOTTLE, PLASTIC (0115-1750-08)Marketed from Jan 4, 2016

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Acitretin
Generic name (nonproprietary)
acitretin
Active ingredients
Acitretin — 10 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Amneal Pharmaceuticals of New York LLCNDC labeler code 0115
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 202552
Marketing start
Listing expires
Other FDA classes
Retinoids (Chemical structure)
Identifiers
Product ID 0115-1750_233bc68a-a24e-4f19-8477-3a11e80e68dfSPL ID 233bc68a-a24e-4f19-8477-3a11e80e68dfSPL set ID 85507f6c-f802-479e-bacc-624b5136d092RxCUI 199689, 199690, 894859, 894863UNII LCH760E9T7UPC 0301151753082, 0301151752085
Pharmacologic class
Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400115175008 followed by a unit qualifier and the quantity

Package 00115-1750-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Acitretin capsules are indicated for the treatment of severe psoriasis in adults. Because of significant adverse effects associated with its use, acitretin capsules should be prescribed only by those knowledgeable in the systemic use of retinoids. In females of reproductive potential, acitretin capsules should be reserved for non-pregnant patients who are unresponsive to other therapies or whose clinical condition contraindicates the use of other treatments (see boxed CONTRAINDICATIONS AND WARNINGS — acitretin capsules can cause severe birth defects). Most patients experience relapse of psoriasis after discontinuing therapy. Subsequent courses, when clinically indicated…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0115-1750

What is NDC 0115-1750?
0115-1750 is the product NDC for Acitretin, Acitretin 10 mg/1 capsule, listed with the FDA by Amneal Pharmaceuticals of New York LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Acitretin.
What is the active ingredient?
Acitretin.
Who is the labeler?
Amneal Pharmaceuticals of New York LLC, NDC labeler code 0115. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Acitretin?
21 other product NDCs are listed under this name. See all Acitretin NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Acitretin NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
AcitretinAcitretin 10 mg/1CapsuleOralAlembic Pharmaceuticals Limited46708-74146708-0741-30
AcitretinAcitretin 17.5 mg/1CapsuleOralAlembic Pharmaceuticals Limited46708-74246708-0742-30
AcitretinAcitretin 25 mg/1CapsuleOralAlembic Pharmaceuticals Limited46708-74346708-0743-30
AcitretinAcitretin 10 mg/1CapsuleOralAlembic Pharmaceuticals Inc.62332-74162332-0741-30
AcitretinAcitretin 17.5 mg/1CapsuleOralAlembic Pharmaceuticals Inc.62332-74262332-0742-30
AcitretinAcitretin 25 mg/1CapsuleOralAlembic Pharmaceuticals Inc.62332-74362332-0743-30
AcitretinAcitretin 10 mg/1CapsuleOralAvKARE42291-08642291-0086-30
AcitretinAcitretin 17.5 mg/1CapsuleOralAvKARE42291-08742291-0087-30
AcitretinAcitretin 25 mg/1CapsuleOralAvKARE42291-08842291-0088-30
AcitretinAcitretin 10 mg/1CapsuleOralMylan Pharmaceuticals Inc.0378-702000378-7020-93

All 22 Acitretin NDCs

Other NDCs under ANDA 202552

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202552
ProductStrengthForm · routeLabelerProduct NDC
AcitretinAcitretin 17.5 mg/1CapsuleOralAmneal Pharmaceuticals of New York LLC0115-1751
AcitretinAcitretin 22.5 mg/1CapsuleOralAmneal Pharmaceuticals of New York LLC0115-1752
AcitretinAcitretin 25 mg/1CapsuleOralAmneal Pharmaceuticals of New York LLC0115-1753

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in